Gene · 3908
Papers2,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biodegradable external wrapping promotes favorable adaptation in an ovine vein graft model. | Acta Biomater | 2022 | 35995404 | PubTator, text mining | PubMed |
| Whole exome sequencing identified a novel LAMA2 frameshift variant causing merosin-deficient congenital muscular dystrophy in a patient with cardiomyopathy, and autism-like behavior. | Neuromuscul Disord | 2022 | 35989179 | PubTator, text mining | PubMed |
| Single-Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2022 | 35986392 | PubTator, text mining | PubMed |
| European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders. | Eur J Neurol | 2022 | 35971866 | PubTator, text mining | PubMed |
| Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer. | Cancers (Basel) | 2022 | 35954405 | PubTator, text mining | PubMed |
| Germline Variants Associated with Nasopharyngeal Carcinoma Predisposition Identified through Whole-Exome Sequencing. | Cancers (Basel) | 2022 | 35954343 | PubTator, text mining | PubMed |
| Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma. | Endocrine | 2022 | 35947334 | PubTator, text mining | PubMed |
| Effect of the COVID-19 pandemic on patients with inherited neuromuscular disorders. | Arq Neuropsiquiatr | 2022 | 35946707 | PubTator, text mining | PubMed |
| Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19. | Front Cell Infect Microbiol | 2022 | 35937696 | PubTator, text mining | PubMed |
| Evidence of Two Novel LAMA2 Variants in a Patient With Muscular Dystrophy: Facing the Challenges of a Certain Diagnosis. | Front Neurol | 2022 | 35928135 | PubTator, text mining | PubMed |
| Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies. | Science | 2022 | 35926050 | PubTator, text mining | PubMed |
| A rare case of arrhythmogenic right ventricular cardiomyopathy associated with LAMA2 mutation: A case report and literature review. | Front Med (Lausanne) | 2022 | 35924034 | PubTator, text mining | PubMed |
| A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism. | Hum Mol Genet | 2022 | 35908287 | PubTator, text mining | PubMed |
| Proceedings of the 25th Annual Meeting of the Portuguese Society of Human Genetics (SPGH - Sociedade Portuguesa de Genética Humana). | Medicine (Baltimore) | 2022 | 35905201 | PubTator, text mining | PubMed |
| 3D in vitro Models of Pathological Skeletal Muscle: Which Cells and Scaffolds to Elect? | Front Bioeng Biotechnol | 2022 | 35898644 | PubTator, text mining | PubMed |
| In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer. | Funct Integr Genomics | 2022 | 35896848 | PubTator, text mining | PubMed |
| Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells. | Pharmaceuticals (Basel) | 2022 | 35890123 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis-Further Impact of Heterozygous Immune Disorder Gene Variants? | J Cardiovasc Dev Dis | 2022 | 35877578 | PubTator, text mining | PubMed |
| Developmental Cues and Molecular Drivers in Myelinogenesis: Revisiting Early Life to Re-Evaluate the Integrity of CNS Myelin. | Curr Issues Mol Biol | 2022 | 35877446 | PubTator, text mining | PubMed |
| Differential Gene Analysis of Trastuzumab in Breast Cancer Based on Network Pharmacology and Medical Images. | Front Physiol | 2022 | 35874525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3908/papers?page=22